ATE467641T1 - Bibliothek von toxin mutanten und deren verwendung - Google Patents

Bibliothek von toxin mutanten und deren verwendung

Info

Publication number
ATE467641T1
ATE467641T1 AT04785852T AT04785852T ATE467641T1 AT E467641 T1 ATE467641 T1 AT E467641T1 AT 04785852 T AT04785852 T AT 04785852T AT 04785852 T AT04785852 T AT 04785852T AT E467641 T1 ATE467641 T1 AT E467641T1
Authority
AT
Austria
Prior art keywords
library
toxin mutants
mutants
toxin
libraries
Prior art date
Application number
AT04785852T
Other languages
English (en)
Inventor
Jean Gariepy
Xin Wei
Original Assignee
Molecular Templates Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Templates Inc filed Critical Molecular Templates Inc
Application granted granted Critical
Publication of ATE467641T1 publication Critical patent/ATE467641T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/25—Shigella (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT04785852T 2004-03-26 2004-03-26 Bibliothek von toxin mutanten und deren verwendung ATE467641T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CA2004/000443 WO2005092917A1 (en) 2004-03-26 2004-03-26 Library of toxin mutants, and methods of using same

Publications (1)

Publication Number Publication Date
ATE467641T1 true ATE467641T1 (de) 2010-05-15

Family

ID=34957323

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04785852T ATE467641T1 (de) 2004-03-26 2004-03-26 Bibliothek von toxin mutanten und deren verwendung

Country Status (9)

Country Link
US (1) US20070298434A1 (de)
EP (2) EP1727827B1 (de)
JP (1) JP4934761B2 (de)
AT (1) ATE467641T1 (de)
AU (1) AU2004317555B2 (de)
CA (1) CA2559536A1 (de)
DE (1) DE602004027168D1 (de)
ES (2) ES2386338T3 (de)
WO (1) WO2005092917A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1945660B1 (de) * 2005-09-26 2014-05-07 Molecular Templates, Inc. Bibliothek aus toxinmutanten und verfahren zu deren anwendung
WO2007071061A1 (en) * 2005-12-23 2007-06-28 Viventia Biotech Inc. Methods for generating and screening fusion protein libraries and uses thereof
US10450354B2 (en) 2013-03-12 2019-10-22 Molecular Templates, Inc. CD20-binding immunotoxins for inducing cellular internalization and methods using same
IL285403B2 (en) 2014-01-27 2023-10-01 Molecular Templates Inc Polypeptides that remove an epitope for MHC group I
EP3102245B1 (de) 2014-02-05 2021-09-08 Molecular Templates, Inc. Verfahren zum abtasten, auswählen und identifizieren von cytotoxischen rekombinanten polypeptiden auf grundlage einer vorläufigen minderung der ribotoxizität
US11142584B2 (en) 2014-03-11 2021-10-12 Molecular Templates, Inc. CD20-binding proteins comprising Shiga toxin A subunit effector regions for inducing cellular internalization and methods using same
EP3137488B1 (de) 2014-06-11 2019-01-02 Molecular Templates, Inc. Proteasespaltungsbeständige shigatoxin-a-untereinheiteffektorpolypeptide und zellgerichtete moleküle damit
KR20170110601A (ko) 2015-02-05 2017-10-11 몰레큘러 템플레이츠, 인코퍼레이션. 시가 독소 a 서브유닛 작동체 영역을 포함하는 다가 cd20 결합 분자 및 이들의 강화된 조성물
HUE051246T2 (hu) 2015-05-30 2021-03-01 Molecular Templates Inc Deimmunizált shigatoxin alegység vázak és azokat tartalmazó, sejthez irányító molekulák
MX2018001208A (es) 2015-07-26 2018-03-26 Molecular Templates Inc Moleculas con direccion a las celulas que comprenden efectores de la subunidad a de la toxina shiga y epitopos de celulas-t cd8+.
JP7075134B2 (ja) 2016-12-07 2022-05-25 モレキュラー テンプレーツ，インク． 部位特異的コンジュゲーションのための志賀毒素ａサブユニットエフェクターポリペプチド、志賀毒素エフェクター足場、及び細胞標的化分子
JP7082424B2 (ja) 2017-01-25 2022-06-08 モレキュラー テンプレーツ，インク． 脱免疫化された志賀毒素ａサブユニットエフェクター及びｃｄ８＋ｔ細胞エピトープを含む細胞標的化分子
KR20200143634A (ko) 2018-04-17 2020-12-24 몰레큘러 템플레이츠, 인코퍼레이션. 탈면역된 시가 독소 a 서브유닛 스캐폴드를 포함하는 her2-표적화 분자
WO2020081493A1 (en) 2018-10-16 2020-04-23 Molecular Templates, Inc. Pd-l1 binding proteins
WO2021055816A1 (en) 2019-09-18 2021-03-25 Molecular Templates, Inc. Pd-l1 binding molecules comprising shiga toxin a subunit scaffolds
EP4031576A1 (de) 2019-09-18 2022-07-27 Molecular Templates, Inc. Pd-l1-bindende moleküle, die gerüste der shiga-toxin-a-untereinheit umfassen
WO2021102445A1 (en) 2019-11-24 2021-05-27 Molecular Templates, Inc. Uses of cd20-binding molecules and additional therapeutic agents
EP4262858A1 (de) 2020-12-16 2023-10-25 Molecular Templates, Inc. Klinische verfahren zur verwendung eines pd-l1-bindenden moleküls mit einem shigatoxineffektor

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5621083A (en) * 1991-11-04 1997-04-15 Xoma Corporation Immunotoxins comprising ribosome-inactivating proteins
US5552144A (en) * 1992-01-22 1996-09-03 Microcarb, Inc. Immunogenic shiga-like toxin II variant mutants
EP0817647A4 (de) * 1995-03-24 2002-10-30 Promega Corp Behandlung von verotoxin-produzierenden escherichia coli
EP0977862B8 (de) * 1997-04-30 2009-09-16 Twinstrand Therapeutics Inc. Ricin-ähnliche toxine zur therapie von kreb, viraler oder parasitärer infektionen
US7314632B1 (en) * 1997-07-11 2008-01-01 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Pseudomonas exotoxin A-like chimeric immunogens
CA2222993A1 (en) * 1998-02-04 1999-08-04 The Ontario Cancer Institute A method for using a ribosome-inactivating protein complex as a structural template and a molecular search engine in the design, construction and screening of combinatorial protein libraries
AU2001238501A1 (en) * 2000-02-16 2001-08-27 Bechtel Bwxt Idaho, Llc Selective destruction of cells infected with human immunodeficiency virus
JP2003527398A (ja) * 2000-03-16 2003-09-16 ユニヴァーシティ オブ ピッツバーグ 内皮特異性ターゲティング
EP1945660B1 (de) * 2005-09-26 2014-05-07 Molecular Templates, Inc. Bibliothek aus toxinmutanten und verfahren zu deren anwendung

Also Published As

Publication number Publication date
AU2004317555B2 (en) 2011-12-01
DE602004027168D1 (de) 2010-06-24
WO2005092917A1 (en) 2005-10-06
EP1727827B1 (de) 2010-05-12
EP1727827A1 (de) 2006-12-06
US20070298434A1 (en) 2007-12-27
AU2004317555A1 (en) 2005-10-06
EP2228383A1 (de) 2010-09-15
ES2344844T3 (es) 2010-09-08
EP2228383B1 (de) 2012-05-23
JP4934761B2 (ja) 2012-05-16
JP2007531716A (ja) 2007-11-08
CA2559536A1 (en) 2005-10-06
ES2386338T3 (es) 2012-08-17

Similar Documents

Publication Publication Date Title
DE602004027168D1 (de) Bibliothek von toxin mutanten und deren verwendung
ATE346056T1 (de) Substituierte phenylacetamide und deren verwendung als glucokinaseaktivatoren
ATE463482T1 (de) Chinolinderivate und deren verwendung als mycobakterielle inhibitoren
DK1824855T3 (da) Hidtil ukendte pyrrolo (3,2-d)pyrimidin-4-onderivater og anvendelser af disse til behandling
DE602004021037D1 (de) Phosphororganische indazolderivate und deren verwendung als proteinkinaseinhibitoren
DE60325761D1 (de) Diaminotriazole derivate und deren verwendung als protein kinase inhibitoren
DE60023903D1 (de) Pyrimidin-2,4,6-trionen und deren verwendung als metalloproteinase inhibitoren
EP1539819A4 (de) Verfahren und zusammensetzungen zur erstellung und steuerung des effektorprofils von t-zellen durch gleichzeitiges beladen und aktivieren ausgewählter untergruppen von antigen-präsentierenden zellen
FI20031503A0 (fi) Liukutyyppinen matkapuhelin ja sen liukumenetelmä
DE60332050D1 (de) Zusammensetzung enthaltend lactobacillus oder bifidobacterium und deren verwendung
DE602004021904D1 (de) Gyraseinhibitoren und deren verwendungen
CR9761A (es) Reduccion de celulas b utilizando moleculas de union especificas cd37 y cd20
DE60328087D1 (de) Aryl substituierte pyrimidine und deren verwendung
DK2018441T3 (da) Mærkede mikroorganismer og fremgangsmåde til mærkning
DE602004030044D1 (de) Bacillus thuringiensis und deren verwendungen
DE60317348D1 (de) Pyrimidinderivate und deren verwendung als cb2-modulatoren
DE50111690D1 (de) 2-acyl-indolderivate und deren verwendung als antitumormittel
ATE487707T1 (de) (6-flu0r-benz0äl, 3üdioxolyl)-morpholin-4-yl- methanone und deren verwendung als cbl-liganden
DE60325493D1 (de) Substituierte 1,4-dipiperidin-4-yl-piperazinderivate und deren verwendung als neurokininantagonisten
DE602005009988D1 (de) Härtbare Zusammensetzung und deren Verwendung
DE602004010284D1 (de) Aminochinolinderivate und deren verwendung als adenosin-a3-liganden
ATE472524T1 (de) Diaminoalkohole und deren verwendung als renininhibitoren
DE502004012314D1 (de) Verfahren zum reaktiv-färben von leder, sowie farbstoffe und deren verwendung
DE60332756D1 (de) Anti-infarkt-moleküle
ATE555097T1 (de) 4-cycloalkyl-substituierte tetrahydrochinolinderivate und deren verwendung als medikamente

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties